DEREK JIMENEZ
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology PENSACOLA, FL NPI 1194846923
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology FL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$667.16
- Category: General Payments
- Program years: PY2018–2023
- Record count: 27
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $145.09 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $131.49 | 5 |
| Education | $13.60 | 1 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.72 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $32.33 | 2 |
| Otsuka America Pharmaceutical, Inc. | $31.10 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.90 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.04 | 1 |
By program year
Records — PY2023 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1000617829 | Bayer Healthcare Pharmaceuticals Inc. | $22.04 | 10/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1014440865 | Otsuka America Pharmaceutical, Inc. | $31.10 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 992351953 | Novartis Pharmaceuticals Corporation | $33.72 | 11/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993481369 | Calliditas Therapeutics US Inc. | $18.73 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993494761 | Calliditas Therapeutics US Inc. | $13.60 | 11/30/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 996928851 | Boehringer Ingelheim Pharmaceuticals, Inc. | $25.90 | 10/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.